170 related articles for article (PubMed ID: 8099613)
21. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic CD4 lymphocytopenia.
Walker UA; Warnatz K
Curr Opin Rheumatol; 2006 Jul; 18(4):389-95. PubMed ID: 16763460
[TBL] [Abstract][Full Text] [Related]
23. No seroconversions among steady sex partners of methadone-maintained HIV-1-seropositive injecting drug users in New York City.
Siddiqui NS; Brown LS; Phillips RY; Vargas O; Makuch RW
AIDS; 1992 Dec; 6(12):1529-33. PubMed ID: 1492936
[TBL] [Abstract][Full Text] [Related]
24. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
[TBL] [Abstract][Full Text] [Related]
25. Decline in Herpes Simplex Virus Type 2 Among Non-Injecting Heroin and Cocaine Users in New York City, 2005 to 2014: Prospects for Avoiding a Resurgence of Human Immunodeficiency Virus.
Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Tross S; Perlman DC; Campbell AN; Hagan H; Cooper HL
Sex Transm Dis; 2017 Feb; 44(2):85-90. PubMed ID: 27898577
[TBL] [Abstract][Full Text] [Related]
26. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
28. Screening of blood donors for idiopathic CD4+ T-lymphocytopenia.
Busch MP; Valinsky JE; Paglieroni T; Prince HE; Crutcher GJ; Gjerset GF; Operskalski EA; Charlebois E; Bianco C; Holland PV
Transfusion; 1994 Mar; 34(3):192-7. PubMed ID: 7908469
[TBL] [Abstract][Full Text] [Related]
29. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
30. [CD4 lymphocytopenia in patients without significant clinical pathology].
Cascio G; Massobrio AM; Cascio B; Bosso E; Anania A
Minerva Med; 1996 Nov; 87(11):539-44. PubMed ID: 9045105
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T-lymphocytopenia without HIV infection.
Heymann DL; Belsey E; Esparza JG
N Engl J Med; 1993 Jun; 328(25):1848; author reply 1849-50. PubMed ID: 8099197
[No Abstract] [Full Text] [Related]
32. Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users.
Brown LS; Siddiqui NS; Chu AF
J Natl Med Assoc; 1996 Jan; 88(1):37-42. PubMed ID: 8583491
[TBL] [Abstract][Full Text] [Related]
33. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
34. Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus.
Alcabes P; Schoenbaum EE; Klein RS
Am J Epidemiol; 1993 May; 137(9):989-1000. PubMed ID: 8100395
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical manifestations of HIV infection between male and female injecting drug users.
Vlahov D; Muñoz A; Solomon L; Astemborski J; Lindsay A; Anderson J; Galai N; Nelson KE
AIDS; 1994 Jun; 8(6):819-23. PubMed ID: 7916193
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic CD4+ T-lymphocytopenia: analysis of a patient with selective IgA deficiency and no evidence of HIV infection.
Vertes D; Linden MD; Carey JL
Cytometry; 1995 Mar; 22(1):40-4. PubMed ID: 7587732
[TBL] [Abstract][Full Text] [Related]
37. Continued drug use and other cofactors for progression to AIDS among injecting drug users.
Ronald PJ; Robertson JR; Elton RA
AIDS; 1994 Mar; 8(3):339-43. PubMed ID: 7913328
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic CD4 lymphocytopenia.
Brooks JP; Ghaffari G
Allergy Asthma Proc; 2016 Nov; 37(6):501-504. PubMed ID: 27931306
[TBL] [Abstract][Full Text] [Related]
40. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
Des Jarlais DC; Vanichseni S; Marmor M; Buavirat A; Titus S; Raktham S; Friedmann P; Kitayaporn D; Wolfe H; Friedman SR; Mastro TD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):393-9. PubMed ID: 9420319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
